Alzheimers Disease Drug Market
1 Alzheimer's Disease Drug Market Overview
1.1 Product Overview and Scope of Alzheimer's Disease Drug
1.2 Alzheimer's Disease Drug Segment by Type
1.2.1 Global Alzheimer's Disease Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.2.5 Others
1.3 Alzheimer's Disease Drug Segment by Application
1.3.1 Global Alzheimer's Disease Drug Sales Comparison by Application: (2021-2027)
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Global Alzheimer's Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Alzheimer's Disease Drug Revenue 2016-2027
1.4.2 Global Alzheimer's Disease Drug Sales 2016-2027
1.4.3 Alzheimer's Disease Drug Market Size by Region: 2016 Versus 2021 Versus 2027
2 Alzheimer's Disease Drug Market Competition by Manufacturers
2.1 Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Alzheimer's Disease Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Alzheimer's Disease Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Alzheimer's Disease Drug Manufacturing Sites, Area Served, Product Type
2.5 Alzheimer's Disease Drug Market Competitive Situation and Trends
2.5.1 Alzheimer's Disease Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Alzheimer's Disease Drug Players Market Share by Revenue
2.5.3 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alzheimer's Disease Drug Retrospective Market Scenario by Region
3.1 Global Alzheimer's Disease Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Alzheimer's Disease Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Alzheimer's Disease Drug Market Facts & Figures by Country
3.3.1 North America Alzheimer's Disease Drug Sales by Country
3.3.2 North America Alzheimer's Disease Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Alzheimer's Disease Drug Market Facts & Figures by Country
3.4.1 Europe Alzheimer's Disease Drug Sales by Country
3.4.2 Europe Alzheimer's Disease Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Alzheimer's Disease Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Alzheimer's Disease Drug Sales by Region
3.5.2 Asia Pacific Alzheimer's Disease Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Alzheimer's Disease Drug Market Facts & Figures by Country
3.6.1 Latin America Alzheimer's Disease Drug Sales by Country
3.6.2 Latin America Alzheimer's Disease Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Alzheimer's Disease Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Alzheimer's Disease Drug Sales by Country
3.7.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Alzheimer's Disease Drug Historic Market Analysis by Type
4.1 Global Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
4.2 Global Alzheimer's Disease Drug Revenue Market Share by Type (2016-2021)
4.3 Global Alzheimer's Disease Drug Price by Type (2016-2021)
5 Global Alzheimer's Disease Drug Historic Market Analysis by Application
5.1 Global Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
5.2 Global Alzheimer's Disease Drug Revenue Market Share by Application (2016-2021)
5.3 Global Alzheimer's Disease Drug Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Allergan Alzheimer's Disease Drug Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Eisai Alzheimer's Disease Drug Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novartis Alzheimer's Disease Drug Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 Merz Pharma
6.5.1 Merz Pharma Corporation Information
6.5.2 Merz Pharma Description and Business Overview
6.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Merz Pharma Alzheimer's Disease Drug Product Portfolio
6.5.5 Merz Pharma Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Pfizer Alzheimer's Disease Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Johnson & Johnson Alzheimer's Disease Drug Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Lundbeck
6.8.1 Lundbeck Corporation Information
6.8.2 Lundbeck Description and Business Overview
6.8.3 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Lundbeck Alzheimer's Disease Drug Product Portfolio
6.8.5 Lundbeck Recent Developments/Updates
7 Alzheimer's Disease Drug Manufacturing Cost Analysis
7.1 Alzheimer's Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Alzheimer's Disease Drug
7.4 Alzheimer's Disease Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Alzheimer's Disease Drug Distributors List
8.3 Alzheimer's Disease Drug Customers
9 Alzheimer's Disease Drug Market Dynamics
9.1 Alzheimer's Disease Drug Industry Trends
9.2 Alzheimer's Disease Drug Growth Drivers
9.3 Alzheimer's Disease Drug Market Challenges
9.4 Alzheimer's Disease Drug Market Restraints
10 Global Market Forecast
10.1 Alzheimer's Disease Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Alzheimer's Disease Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Alzheimer's Disease Drug by Type (2022-2027)
10.2 Alzheimer's Disease Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Alzheimer's Disease Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Alzheimer's Disease Drug by Application (2022-2027)
10.3 Alzheimer's Disease Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Alzheimer's Disease Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Alzheimer's Disease Drug by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Alzheimer's Disease Drug Sales (M Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Alzheimer's Disease Drug Sales (M Units) Comparison by Application (2021-2027)
Table 3. Global Alzheimer's Disease Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Alzheimer's Disease Drug Covered in This Study
Table 5. Global Alzheimer's Disease Drug Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Alzheimer's Disease Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Alzheimer's Disease Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Alzheimer's Disease Drug Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Alzheimer's Disease Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Alzheimer's Disease Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Alzheimer's Disease Drug Sales by Region (2016-2021) & (M Units)
Table 16. Global Alzheimer's Disease Drug Sales Market Share by Region (2016-2021)
Table 17. Global Alzheimer's Disease Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Alzheimer's Disease Drug Sales by Country (2016-2021) & (M Units)
Table 19. North America Alzheimer's Disease Drug Sales Market Share by Country (2016-2021)
Table 20. North America Alzheimer's Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Alzheimer's Disease Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Alzheimer's Disease Drug Sales by Country (2016-2021) & (M Units)
Table 23. Europe Alzheimer's Disease Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Alzheimer's Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Alzheimer's Disease Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Alzheimer's Disease Drug Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Alzheimer's Disease Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Alzheimer's Disease Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Alzheimer's Disease Drug Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Alzheimer's Disease Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Alzheimer's Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Alzheimer's Disease Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Alzheimer's Disease Drug Sales (M Units) by Type (2016-2021)
Table 39. Global Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Table 40. Global Alzheimer's Disease Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Alzheimer's Disease Drug Revenue Share by Type (2016-2021)
Table 42. Global Alzheimer's Disease Drug Price (US$/Unit) by Type (2016-2021)
Table 43. Global Alzheimer's Disease Drug Sales (M Units) by Application (2016-2021)
Table 44. Global Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Table 45. Global Alzheimer's Disease Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Alzheimer's Disease Drug Revenue Share by Application (2016-2021)
Table 47. Global Alzheimer's Disease Drug Price (US$/Unit) by Application (2016-2021)
Table 48. Allergan Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Allergan Alzheimer's Disease Drug Product
Table 52. Allergan Recent Developments/Updates
Table 53. Eisai Corporation Information
Table 54. Eisai Description and Business Overview
Table 55. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Eisai Alzheimer's Disease Drug Product
Table 57. Eisai Recent Developments/Updates
Table 58. Novartis Corporation Information
Table 59. Novartis Description and Business Overview
Table 60. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Novartis Alzheimer's Disease Drug Product
Table 62. Novartis Recent Developments/Updates
Table 63. Daiichi Sankyo Corporation Information
Table 64. Daiichi Sankyo Description and Business Overview
Table 65. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Daiichi Sankyo Alzheimer's Disease Drug Product
Table 67. Daiichi Sankyo Recent Developments/Updates
Table 68. Merz Pharma Corporation Information
Table 69. Merz Pharma Description and Business Overview
Table 70. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Merz Pharma Alzheimer's Disease Drug Product
Table 72. Merz Pharma Recent Developments/Updates
Table 73. Pfizer Corporation Information
Table 74. Pfizer Description and Business Overview
Table 75. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Pfizer Alzheimer's Disease Drug Product
Table 77. Pfizer Recent Developments/Updates
Table 78. Johnson & Johnson Corporation Information
Table 79. Johnson & Johnson Description and Business Overview
Table 80. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Johnson & Johnson Alzheimer's Disease Drug Product
Table 82. Johnson & Johnson Recent Developments/Updates
Table 83. Lundbeck Corporation Information
Table 84. Lundbeck Description and Business Overview
Table 85. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Lundbeck Alzheimer's Disease Drug Product
Table 87. Lundbeck Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Alzheimer's Disease Drug Distributors List
Table 91. Alzheimer's Disease Drug Customers List
Table 92. Alzheimer's Disease Drug Market Trends
Table 93. Alzheimer's Disease Drug Growth Drivers
Table 94. Alzheimer's Disease Drug Market Challenges
Table 95. Alzheimer's Disease Drug Market Restraints
Table 96. Global Alzheimer's Disease Drug Sales Forecast by Type (2022-2027) & (M Units)
Table 97. Global Alzheimer's Disease Drug Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Alzheimer's Disease Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Alzheimer's Disease Drug Sales Forecast by Application (2022-2027) & (M Units)
Table 101. Global Alzheimer's Disease Drug Sales Market Share Forecast by Application (2022-2027)
Table 102. Global Alzheimer's Disease Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global Alzheimer's Disease Drug Sales Forecast by Region (2022-2027) & (M Units)
Table 105. Global Alzheimer's Disease Drug Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Alzheimer's Disease Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alzheimer's Disease Drug
Figure 2. Global Alzheimer's Disease Drug Market Share by Type in 2020 & 2027
Figure 3. Donepezil Product Picture
Figure 4. Memantine Product Picture
Figure 5. Rivastigmine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Alzheimer's Disease Drug Market Share by Application in 2020 & 2027
Figure 8. Early to Moderate Stages
Figure 9. Moderate to Severe Stages
Figure 10. Global Alzheimer's Disease Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Alzheimer's Disease Drug Market Size 2016-2027 (US$ Million)
Figure 12. Global Alzheimer's Disease Drug Sales 2016-2027 (M Units)
Figure 13. Global Alzheimer's Disease Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Alzheimer's Disease Drug Sales Share by Manufacturers in 2020
Figure 15. Global Alzheimer's Disease Drug Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Alzheimer's Disease Drug Players: Market Share by Revenue in 2020
Figure 17. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Alzheimer's Disease Drug Sales Market Share by Region (2016-2021)
Figure 19. Global Alzheimer's Disease Drug Sales Market Share by Region in 2020
Figure 20. Global Alzheimer's Disease Drug Revenue Market Share by Region (2016-2021)
Figure 21. Global Alzheimer's Disease Drug Revenue Market Share by Region in 2020
Figure 22. U.S. Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Taiwan Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Colombia Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Alzheimer's Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Alzheimer's Disease Drug by Type (2016-2021)
Figure 46. Sales Market Share of Alzheimer's Disease Drug by Application (2016-2021)
Figure 47. Sales Market Share of Alzheimer's Disease Drug by Application in 2020
Figure 48. Revenue Share of Alzheimer's Disease Drug by Application (2016-2021)
Figure 49. Revenue Share of Alzheimer's Disease Drug by Application in 2020
Figure 50. Manufacturing Cost Structure of Alzheimer's Disease Drug
Figure 51. Manufacturing Process Analysis of Alzheimer's Disease Drug
Figure 52. Alzheimer's Disease Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
